The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.
Derrick McVicker
Advertisement
Derrick McVicker, PhD, is group leader at PPD Laboratories’ GMP cell lab.
Articles by Derrick McVicker
Advertisement
Latest Updated Articles
Development Strategies for Cell and Gene Therapy MethodsPublished: June 1st 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
5
